AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 NOV 6 - (NewsRx.com & NewsRx.net) -- Acetylated Sp3 is a transcriptional activator.
According to a study from the United States, "Sp3 transcription factor can either activate or repress target gene expression.
"However, the molecular event that controls this dual function is unclear. We previously reported (Ammanamanchi S and Brattain MG, J Biol Chem, 2001;276, 3348-3352) that unmodified Sp3 acts as a transcriptional repressor of transforming growth factor-beta receptors in MCF-7L breast cancer cells," wrote S. Ammanamanchi and colleagues, Roswell Park Cancer Institute, Department of Pharmacology & Therapeutics.
"We now report that histone deacetylase inhibitor trichostatin A (TSA) induces acetylation of Sp3, which acts as a transcriptional activator of transforming growth factor-beta receptor type II (RII) in MCF-7L cells. Mutation analysis indicated the TSA response is mediated through a GC box located on the RII promoter, which was previously identified as an Sp1/Sp3-binding site that was critical for RII promoter activity," the researchers wrote.
"Ectopic Sp3 expression in Sp3-deficient MCF-7E breast cancer cells repressed RII promoter activity in the absence of TSA. However, in the TSA-treated MCF-7E cells ectopic Sp3 activated RII promoter," the researchers ...